Nationwide Fund Advisors’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIV
NMC
MAM
RG
USAA
BCM
Nationwide Fund Advisors's TRIV Position: Q2 2015 in Review
Nationwide Fund Advisors sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q2 2015, closing a stake of 5,712 shares — an estimated $60K sold.
Nationwide Fund Advisors first reported a position in TRIV in Q2 2014 and held it in 4 quarters. The position peaked at $207K in Q2 2014. 36 funds tracked by Wall St. Rank hold TRIV as of Q2 2015.
- Nationwide Fund Advisors reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q2 2015 after selling out during the quarter.
- Nationwide Fund Advisors sold 5,712 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q2 2015, an estimated $60K.
- Nationwide Fund Advisors first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 4 quarters.
- Nationwide Fund Advisors's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $207K in Q2 2014.
- 36 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q2 2015.
Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.